I call the meeting to order.
Pursuant to Standing Order 108(2), this is a study of the post-market surveillance of pharmaceutical products.
We have a number of witnesses with us today. We have the Auditor General, Sheila Fraser, and Neil Maxwell from the Office of the Auditor General; as well, from the Office of the Privacy Commissioner of Canada, Jennifer Stoddart, the Privacy Commissioner herself, as well as Patricia Kosseim, general counsel. From Canada Health Infoway, we have Richard Alvarez, president and chief executive officer, as well as Mike Sheridan, chief operating officer. Welcome.
I think we all know that each group has 10 minutes to make a statement, and then questioning starts thereafter.
We'll start with Madame Fraser.